Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 



Register here to be notified of future BCT Company articles
View full BCT profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015
Newswire
August 28 2014

Related Articles

bluechiip-andrew-mclelland-presenting-Syd-Mar-2017.png
March 16 2017
Andrew McLellan discussed with investors wiresless tracking technology.
financialanalysis.jpg
December 07 2016
Buy-and-build: Be Heard plans to build a mid-sized network that combines scale, expertise and agility
Stove-with-burners.png
November 03 2016
Relationships with some of the housing industry's leading suppliers help drive sales, profit

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use